Showing results (2481-2490 of 2,708) with videos related to
Sort By:
Pageof 271
Journal of Neural Engineering|May 20, 2014
Performance measurement for brain-computer or brain-machine interfaces: a tutorialDavid E Thompson, Lucia R Quitadamo, Luca Mainardi, et al.Journal of the American Heart Association|January 29, 2026
Recurrent Symptomatic Hemorrhage in Cerebral Cavernous Malformations After Discontinuation of Atorvastatin or PlaceboBader Ali, Robert Shenkar, Justine Lee, et al.Chemosphere|June 17, 2018
Comparative metagenomics reveals different hydrocarbon degradative abilities from enriched oil-drilling wasteAmanda P Napp, José Evandro S Pereira, Jorge S Oliveira, et al.Blood|November 21, 2014
Mito-protective autophagy is impaired in erythroid cells of aged mtDNA-mutator miceXiuJie Li-Harms, Sandra Milasta, John Lynch, et al.ACS Infectious Diseases|September 15, 2016
A Novel Chemical Biology Approach for Mapping of Polymyxin Lipopeptide Antibody Binding EpitopesTony Velkov, Bo Yun, Elena K Schneider, et al.American Journal of Epidemiology|December 18, 2001
Design and serendipity in establishing a large cohort with wide dietary intake distributions : the National Institutes of Health-American Association of Retired Persons Diet and Health StudyA Schatzkin, A F Subar, F E Thompson, et al.Journal of the Academy of Nutrition and Dietetics|August 22, 2020
Performance and Feasibility of Recalls Completed Using the Automated Self-Administered 24-Hour Dietary Assessment Tool in Relation to Other Self-Report Tools and Biomarkers in the Interactive Diet and Activity Tracking in AARP (IDATA) StudyAmy F Subar, Nancy Potischman, Kevin W Dodd, et al.Neurology|September 10, 2017
CSF inflammatory response after intraventricular hemorrhageMaged D Fam, Hussein A Zeineddine, Javed Khader Eliyas, et al.Stroke|June 11, 2019
Influence of Intracerebral Hemorrhage Location on Outcomes in Patients With Severe Intraventricular HemorrhageVahid Eslami, Pouya Tahsili-Fahadan, Lucia Rivera-Lara, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 10, 2012
Antitumour activity of docetaxel following treatment with the CYP17A1 inhibitor abiraterone: clinical evidence for cross-resistance?J Mezynski, C Pezaro, D Bianchini, et al.Pageof 271